(Q35681172)

9 August 2017

title

Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis (English)

1 reference

9 August 2017

Amelia E B Moore

1

1 reference

9 August 2017

Glen M Blake

2

1 reference

9 August 2017

Kathleen A Taylor

3

1 reference

9 August 2017

Valerie A Ruff

4

1 reference

9 August 2017

Asad E Rana

5

1 reference

9 August 2017

Xiaohai Wan

6

1 reference

9 August 2017

Ignac Fogelman

7

1 reference

9 August 2017

publication date

5 November 2011

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

9 August 2017

published in

1 reference

9 August 2017

volume

39

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

326-336

1 reference

Miscellaneous indications in bone scintigraphy: metabolic bone diseases and malignant bone tumors.

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261405

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261405

Evaluation of accuracy in activity calculations for the conjugate view method from Monte Carlo simulated scintillation camera images using experimental data in an anthropomorphic phantom

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261405

Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261405

Osteoporosis prevention, diagnosis, and therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261405

Updated data on proximal femur bone mineral levels of US adults

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261405

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261405

Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261405

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

27 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1974-Y

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1974-Y

Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1974-Y

Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1974-Y

Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1974-Y

Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1974-Y

Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1974-Y

Validation of ultrafiltration as a method of measuring free 99mTc-MDP.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261405

Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment

25 September 2018

1 reference

12 December 2020

The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease

1 reference

12 December 2020

Quantification of diphosphonate uptake based on conventional bone scanning

1 reference

12 December 2020

Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis

1 reference

12 December 2020

Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis

1 reference

12 December 2020

Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis

1 reference

12 December 2020

Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling

1 reference

12 December 2020

Rapid and robust response of biochemical markers of bone formation to teriparatide therapy

1 reference

12 December 2020

Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women

1 reference

12 December 2020

10.1007/S00259-011-1974-Y

Identifiers

DOI

1 reference

9 August 2017

1 reference

9 August 2017

1 reference